NUKZ vs. ESPR
NUKZ (Range Nuclear Renaissance ETF) is Energy Equities fund tracking the Range Nuclear Renaissance Index, while ESPR (Esperion Therapeutics, Inc.) is a stock. Over the past year, NUKZ returned 27.91% vs 162.50% for ESPR. At a 0.19 correlation, their price movements are largely independent.
Performance
NUKZ vs. ESPR - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, NUKZ achieves a 7.57% return, which is significantly higher than ESPR's -14.86% return.
NUKZ
- 1D
- 1.59%
- 1M
- -5.07%
- YTD
- 7.57%
- 6M
- 4.81%
- 1Y
- 27.91%
- 3Y*
- —
- 5Y*
- —
- 10Y*
- —
ESPR
- 1D
- 0.00%
- 1M
- 0.96%
- YTD
- -14.86%
- 6M
- -18.18%
- 1Y
- 162.50%
- 3Y*
- 35.36%
- 5Y*
- -34.62%
- 10Y*
- -14.95%
NUKZ vs. ESPR - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | |
|---|---|---|---|
NUKZ Range Nuclear Renaissance ETF | 7.57% | 56.57% | 60.11% |
ESPR Esperion Therapeutics, Inc. | -14.86% | 68.18% | 3.29% |
Correlation
The correlation between NUKZ and ESPR is 0.25, which is low. Their price movements are largely independent, making them effective diversification partners.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.25 |
Correlation (All Time) Calculated using the full available price history since Jan 24, 2024 | 0.19 |
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
NUKZ vs. ESPR — Risk / Return Rank
NUKZ
ESPR
NUKZ vs. ESPR - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Range Nuclear Renaissance ETF (NUKZ) and Esperion Therapeutics, Inc. (ESPR). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| NUKZ | ESPR | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -0.84 | ||
| Sortino ratioReturn per unit of downside risk | -1.43 | ||
| Omega ratioGain probability vs. loss probability | 1.17 | 1.36 | -0.19 |
| Calmar ratioReturn relative to maximum drawdown | 1.70 | 3.07 | -1.38 |
| Martin ratioReturn relative to average drawdown | 4.11 | 7.68 | -3.57 |
Loading charts...
Drawdowns
NUKZ vs. ESPR - Drawdown Comparison
The maximum NUKZ drawdown since its inception was -33.03%, smaller than the maximum ESPR drawdown of -99.37%. Use the drawdown chart below to compare losses from any high point for NUKZ and ESPR.
Loading charts...
Drawdown Indicators
| NUKZ | ESPR | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -33.03% | -99.37% | +66.34% |
Max Drawdown (1Y)Largest decline over 1 year | -16.51% | -53.19% | +36.68% |
Max Drawdown (3Y)Largest decline over 3 years | — | -80.94% | — |
Max Drawdown (5Y)Largest decline over 5 years | — | -97.16% | — |
Max Drawdown (10Y)Largest decline over 10 years | — | -99.10% | — |
Current DrawdownCurrent decline from peak | -10.39% | -97.27% | +86.88% |
Average DrawdownAverage peak-to-trough decline | -6.06% | -69.99% | +63.93% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 6.80% | 21.30% | -14.50% |
Volatility
NUKZ vs. ESPR - Volatility Comparison
Range Nuclear Renaissance ETF (NUKZ) has a higher volatility of 11.24% compared to Esperion Therapeutics, Inc. (ESPR) at 1.06%. This indicates that NUKZ's price experiences larger fluctuations and is considered to be riskier than ESPR based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| NUKZ | ESPR | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 11.24% | 1.06% | +10.18% |
Volatility (6M)Calculated over the trailing 6-month period | 23.34% | 61.44% | -38.10% |
Volatility (1Y)Calculated over the trailing 1-year period | 30.46% | 92.66% | -62.20% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 32.94% | 91.79% | -58.85% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 32.94% | 84.61% | -51.67% |
Dividends
NUKZ vs. ESPR - Dividend Comparison
NUKZ's dividend yield for the trailing twelve months is around 0.85%, while ESPR has not paid dividends to shareholders.
| Position | TTM | 2025 | 2024 |
|---|---|---|---|
ESPR Esperion Therapeutics, Inc. | 0.00% | 0.00% | 0.00% |
NUKZ Range Nuclear Renaissance ETF | 0.85% | 0.91% | 0.09% |
Frequently Asked Questions
NUKZ and ESPR have a correlation of 0.25, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
NUKZ has higher volatility (11.24%) compared to ESPR (1.06%). In terms of maximum drawdown, NUKZ dropped -33.03% vs ESPR's -99.37%.
ESPR currently has the higher Sharpe Ratio (1.76 vs 0.92), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for NUKZ and ESPR
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer